<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gomez-Gonzalez PJ</submitter><funding>Newton Institutional Links</funding><funding>Medical Research Council</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>bbac256</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9487601</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(5)</volume><pubmed_abstract>With >1 million associated deaths in 2020, human tuberculosis (TB) caused by the bacteria Mycobacterium tuberculosis remains one of the deadliest infectious diseases. A plethora of genomic tools and bioinformatics pipelines have become available in recent years to assist the whole genome sequencing of M. tuberculosis. The Oxford Nanopore Technologies (ONT) portable sequencer is a promising platform for cost-effective application in clinics, including personalizing treatment through detection of drug resistance-associated mutations, or in the field, to assist epidemiological and transmission investigations. In this study, we performed a comparison of 10 clinical isolates with DNA sequenced on both long-read ONT and (gold standard) short-read Illumina HiSeq platforms. Our analysis demonstrat</pubmed_abstract><journal>Briefings in bioinformatics</journal><pubmed_title>Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications.</pubmed_title><pmcid>PMC9487601</pmcid><funding_grant_id>MR/N010469/1</funding_grant_id><funding_grant_id>261868591</funding_grant_id><funding_grant_id>MR/M01360X/1</funding_grant_id><funding_grant_id>MR/R025576/1</funding_grant_id><funding_grant_id>BB/R013063/1</funding_grant_id><funding_grant_id>MR/R020973/1</funding_grant_id><pubmed_authors>Campino S</pubmed_authors><pubmed_authors>Phelan JE</pubmed_authors><pubmed_authors>Gomez-Gonzalez PJ</pubmed_authors><pubmed_authors>Clark TG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications.</name><description>With >1 million associated deaths in 2020, human tuberculosis (TB) caused by the bacteria Mycobacterium tuberculosis remains one of the deadliest infectious diseases. A plethora of genomic tools and bioinformatics pipelines have become available in recent years to assist the whole genome sequencing of M. tuberculosis. The Oxford Nanopore Technologies (ONT) portable sequencer is a promising platform for cost-effective application in clinics, including personalizing treatment through detection of drug resistance-associated mutations, or in the field, to assist epidemiological and transmission investigations. In this study, we performed a comparison of 10 clinical isolates with DNA sequenced on both long-read ONT and (gold standard) short-read Illumina HiSeq platforms. Our analysis demonstrat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-27T18:55:35.76Z</modification><creation>2025-02-19T04:38:12.971Z</creation></dates><accession>S-EPMC9487601</accession><cross_references><pubmed>35894606</pubmed><doi>10.1093/bib/bbac256</doi></cross_references></HashMap>